Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
75

Summary

Conditions
  • Acute Lymphoblastic Leukemia
  • Refractory Non Hodgkin Lymphoma
  • Relapsed Non Hodgkin Lymphoma
Type
Interventional
Phase
Phase 1Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Younger than 21 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02625480
Collaborators
Not Provided
Investigators
Study Director: Kite Study Director Kite, A Gilead Company